abivertinib,abiraterone
sorrento therapeutics
['crpc', 'maverick']
excited to showcase the maverick trial. the first hsd3b1 selected study in mcrpc. #asco2023 
GU medical oncologist @UCSanDiego, mom, wife, avid runner. Kidney and prostate cancer research. Tweets are my own and not medical advice.